Online Store

Sponsored by MannKind Corporation, this clinical webinar is intended to provide an overview of the unmet medical need for people with diabetes, despite advancements in treatment and technology.

In this session, we will examine three public health initiatives at the national, state and local levels and explore how DCESs added value to each effort.

In this session participants will be equipped with knowledge of the key take away and guidance on the new guidelines and ways to incorporate strategies in their Lifestyle Change Program.

Practical strategies highlighting best practices drawn from the research literature will be shared with diabetes care and education professionals who manage patients with chronic diseases for maximizing success with positive behavior change.

In this moderated panel session, leading experts in this field will cover new research and strategies shown to be effective in reducing weight stigma among different populations.

This session will examine the trends in youth onset diabetes prevalence over the past 20 years, review the progression of youth onset T2D from the TODAY study, and identify the complications that may arise in youth onset T2D.

This session will review the clinical utilization of U-500 in diabetes care, including safety concerns and processes at three different institutions.

Sponsored by Genentech.

This session presents results from a CDC project focused on expanding access to and tailoring the program to effectively reach communities.

Sponsored by Dexcom, this webinar explores the powerful features and benefits of the personal and professional Dexcom G6 CGM systems that support individualized treatment plans in diabetes management.

This online course focuses on diabetes-related cardiometabolic co-conditions: depression and anxiety, liver disease, diabetes-related neuropathies, overweight and obesity, and cardiovascular and renal co-conditions. Learn how to assess diabetes-related co-conditions and the treatment options that are available for each co-condition.

Sponsored by Dexcom, learn more about the glycemic benefits of incorporating a Dexcom CGM System during key times for people with diabetes.

This program will provide an update on currently available technology and its role in patient care as well as a look into what is expected to be FDA approved in the next 6-12 months.

The program will overview how the MedStar Diabetes Boot Camp team partnered with primary care physicians and endocrinologists to implement a comprehensive DSMES and Medication Management Program to overcome therapeutic inertia.

This presentation will highlight that the value of the DCES can be monetized in the device training process and will help attendees understand billing codes to use, when and how to use them. Having this knowledge increases the value of the DCES in primary care, endocrinology and private practice models.

Sponsored by Provention Bio.

This session will review the use of blood glucose monitors, continuous glucose sensors and the role of the DCES in open-ended discussions around improving TIR.

Review the unique health beliefs that can influence people from different cultural backgrounds when providing diabetes prevention education

This session will focus on strategies and tools that inpatient DCESs can use to support both patients and interdisciplinary teams.

Learn about new resources designed to allow lifestyle coaches, and their mentors, to assess key competencies, enhance coaching quality, and identify opportunities for continuous improvement in the diabetes prevention program.

This interactive symposium, with charismatic expert clinicians presenting information in a conversational style on the Med Table Talk™ platform, will focus on overcoming clinical inertia, weight loss as a treatment target, why it is important to understand the newest data on the role and effects of incretins, and shared decision making for sustained weight loss and glucose management. 

Learn about key features and functionality unique to the Omnipod DASH^® Insulin Management System, designed to simplify diabetes management.

In this session, we will examine the growth of technology, available and emerging apps and the benefits of leveraging technology to promote equitable care for people with diabetes.

Learn about the FreeStyle Libre 3 system, the smallest and thinnest sensor available that provides minute-to-minute glucose readings that stream directly to the users' compatible smartphone.

This session will review current evidence-based recommendations for the management of peripheral neuropathy